Recent News

• 08.11.2025 - Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference
• 08.06.2025 - Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis
• 07.22.2025 - Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis
• 05.29.2025 - Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
• 05.27.2025 - Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT
• 04.29.2025 - Cardiol Therapeutics Nominates Dr. Timothy Garnett to its Board of Directors

Recent Filings

• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.06.2025 - EX-99.1 EX-99.1
• 07.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 07.22.2025 - EX-99.1 EX-99.1
• 05.29.2025 - EX-99.1 EX-99.1
• 05.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.27.2025 - EX-99.1 EX-99.1
• 05.27.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]